Chabiotech invests 60B KRW in healthcare fund
차바이오텍
085660
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=616
Risk-adjusted indicator based on 616 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Acquisition Amount: 60,000,000,000 KRW
- • Ratio to Total Equity: 7.41%
- • Post-acquisition Ownership Stake in Fund: 28.99%
- • Fund Total Committed Capital: 207,000,000,000 KRW
- • Acquisition Scheduled Date: 2026-06-26
AI Analysis Summary
Chabiotech Co.,Ltd. decided to invest 60 billion KRW (approximately 7.41% of its equity) as a Limited Partner (LP) in 'Pium AI Future Healthcare New Technology Financial Investment Association'. This investment aims to secure an LP position in the fund, which will acquire existing shares of the subsidiary, CHA Healthcare Co., Ltd. The acquisition is scheduled for June 26, 2026, and will result in a 28.99% ownership stake in the investment fund. The fund's total committed capital is 207 billion KRW. This move is a strategic investment in a healthcare-focused fund, indicating a long-term commitment to the sector.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.